Cargando…
Involvement of Ceramide Metabolism in Cerebral Ischemia
Ischemic stroke, caused by the interruption of blood flow to the brain and subsequent neuronal death, represents one of the main causes of disability in worldwide. Although reperfusion therapies have shown efficacy in a limited number of patients with acute ischemic stroke, neuroprotective drugs and...
Autores principales: | Ouro, Alberto, Correa-Paz, Clara, Maqueda, Elena, Custodia, Antía, Aramburu-Núñez, Marta, Romaus-Sanjurjo, Daniel, Posado-Fernández, Adrián, Candamo-Lourido, María, Alonso-Alonso, Maria Luz, Hervella, Pablo, Iglesias-Rey, Ramón, Castillo, José, Campos, Francisco, Sobrino, Tomás |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067562/ https://www.ncbi.nlm.nih.gov/pubmed/35531465 http://dx.doi.org/10.3389/fmolb.2022.864618 |
Ejemplares similares
-
Ceramide Metabolism and Parkinson’s Disease—Therapeutic Targets
por: Custodia, Antía, et al.
Publicado: (2021) -
Stress Granules and Acute Ischemic Stroke: Beyond mRNA Translation
por: Aramburu-Núñez, Marta, et al.
Publicado: (2022) -
CD34(+) progenitor cells as diagnostic and therapeutic targets in Alzheimer’s disease
por: Romaus-Sanjurjo, Daniel, et al.
Publicado: (2022) -
Ceramide/Sphingosine 1-Phosphate Axis as a Key Target for Diagnosis and Treatment in Alzheimer’s Disease and Other Neurodegenerative Diseases
por: Custodia, Antía, et al.
Publicado: (2022) -
Unraveling the potential of endothelial progenitor cells as a treatment following ischemic stroke
por: Custodia, Antía, et al.
Publicado: (2022)